Horn Announces New Human Nutrition Division
The division includes Horn FoodTech, Horn Nutraceuticals, and Nutri Granulations.
Photo © iStockphoto.com/svanhorn
Horn (La Mirada, CA), a North American distributor of raw materials, ingredients, and chemicals, recently announced it’s reorganizing its distribution business structure with the creation of a new division, HORN Human Nutrition. The new division includes Horn FoodTech, Horn Nutraceuticals, and Nutri Granulations, Horn’s manufacturing arm.
“The creation of Horn Human Nutrition expands our capacity for serving our valued partners and fortifies our company’s leadership within the functional foods, nutraceuticals, pharmaceuticals, and other human nutrition markets,” says Kevin Salerno, president, Horn Human Nutrition. “There are natural crossovers within these markets and the formation of this new division provides a platform for Horn to better serve the industry and maximize business opportunities within existing partnerships.”
Additionally, Jacqueline Grisotti, a 22-year sales and business-development veteran of Horn, has been promoted to sales manager of Horn FoodTech.
“Without a doubt, we are poised for significant growth with the creation of Horn Human Nutrition and the availability of additional resources and opportunities for our teams,” says Grisotti.
Read more:
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
